PerPrev-CID
Aiming to revolutionise personalised prevention and early treatment in chronic inflammatory diseases (CIDs), the PerPrev-CID project focuses on advancing risk prediction, early detection of disease progression, and innovative preventive approaches in rheumatoid arthritis (RA) and Inflammatory Bowel Disease (IBD).
Chronic inflammatory diseases like RA and IBD significantly burden healthcare systems across Europe.
Despite treatment progress, gaps remain in risk prediction and prevention.
The European research project PerPrev-CID (Personalised Disease Prediction and Prevention in Chronic Inflammatory Disorders) fills this gap by exploring new standards for early molecular diagnosis and novel assessment tools. Coordinated by the University Hospital Schleswig-Holstein (UKSH) and Kiel University bringing together fifteen international partners from nine countries, the project will receive a total funding of 11 million Euros from the European Union’s Horizon Europe Framework Programme for Research and Innovation over the next five years. In addition, the Swiss government will contribute over 2.5 million Euros in funding for the Swiss Associate Partners.
Patient Advisory Panel Meeting
On 17 December, the Patient Advisory Panel (PAP) of the PerPrev-CID project held its latest meeting, bringing together patient representatives and project partners to continue strengthening a patient-centred approach. During the session, Dr. Florian Tran from the University of Kiel delivered a clear and accessible presentation on the studies he is leading within the project, explaining their objectives, methodology, and potential impact in a way that was understandable and reassuring for participants.
Thanks to the collaboration between IFCCA and EULAR, the PAP offers an important space where patients can actively share their perspectives, ask questions, and express concerns. Their participation ensures that the PerPrev-CID project reflects real-world experiences and priorities from the IBD and RA community, helping make the research more relevant, understandable, and meaningful for the people it aims to benefit.
